Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Livanova Plc OR Sh (LIVN)

Livanova Plc OR Sh (LIVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,065,560
  • Shares Outstanding, K 49,024
  • Annual Sales, $ 934,240 K
  • Annual Income, $ -345,010 K
  • 60-Month Beta 0.90
  • Price/Sales 4.40
  • Price/Cash Flow 23.39
  • Price/Book 4.00
Trade LIVN with:

Options Overview

Details
  • Implied Volatility 40.24%
  • Historical Volatility 23.51%
  • IV Percentile 8%
  • IV Rank 17.19%
  • IV High 72.16% on 03/10/21
  • IV Low 33.61% on 09/15/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 136
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 390

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.45
  • Number of Estimates 3
  • High Estimate 0.48
  • Low Estimate 0.43
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +18.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.51 +5.63%
on 08/19/21
86.89 -4.56%
on 09/02/21
+2.50 (+3.11%)
since 08/17/21
3-Month
74.73 +10.97%
on 08/11/21
89.17 -7.00%
on 07/29/21
-1.07 (-1.27%)
since 06/17/21
52-Week
41.07 +101.92%
on 09/24/20
90.25 -8.11%
on 04/28/21
+37.57 (+82.83%)
since 09/17/20

Most Recent Stories

More News
Pediatric Perfusion Products Market- Outlook with Trends, Types, Applications, and Opportunity Outlook 2028

Research Nester published a report titled  which delivers detailed overview of the pediatric perfusion products market in terms of market segmentation by product, by end user, and by region.

MDT : 129.70 (-0.93%)
MASI : 274.45 (+0.18%)
LIVN : 82.93 (-1.01%)
GE : 100.47 (-0.86%)
LivaNova to Present at the Baird 2021 Global Healthcare Conference

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Baird 2021 Global Healthcare Conference...

LIVN : 82.93 (-1.01%)
LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the early retirement of its $450 million five-year senior secured term loan (the Term Loan). To retire...

LIVN : 82.93 (-1.01%)
LivaNova Prices Offering of Ordinary Shares

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the public...

LIVN : 82.93 (-1.01%)
LivaNova Announces Offering of Ordinary Shares

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has commenced an underwritten offering of $300 million of its ordinary shares. LivaNova also intends...

LIVN : 82.93 (-1.01%)
Prosthetic Heart Valve/ Artificial Heart Valve Market Size 2021 | Industry Share, Future Growth, Business Challenges, Investment Opportunities, Covid-19 Impact, Key Manufacturers and 2027 Forecast Research Report

Market Research Engine has published a new report titled as "Prosthetic Heart Valve/ Artificial Heart Valve Market By Product (Trans catheter Heart Valves, Mechanical Heart Valves, Tissue Heart Valves);...

CRY : 23.94 (-2.80%)
EW : 119.42 (-1.05%)
LIVN : 82.93 (-1.01%)
MDT : 129.70 (-0.93%)
NVCN.TO : 0.97 (+2.11%)
Transcatheter Mitral Valve Repair & Replacement Market Size, Share, Industry, Price, Analysis, Trends, Report and Forecast 2020-2027

Japan, Japan, Thu, 29 Jul 2021 02:19:59 / Comserve Inc. / -- Competitive Analysis: Abbott Laboratories, Biotronik Pvt Ltd, Colibri Heart Valve, LLC, Edward Lifesciences, HLT Medical, LivaNova Plc, Medtronic...

ABT : 126.79 (-0.51%)
LIVN : 82.93 (-1.01%)
MDT : 129.70 (-0.93%)
NVCN.TO : 0.97 (+2.11%)
LivaNova (LIVN) Q2 Earnings and Revenues Top Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 62.50% and 9.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

LIVN : 82.93 (-1.01%)
LivaNova: Q2 Earnings Snapshot

LONDON (AP) _ LivaNova PLC (LIVN) on Wednesday reported a loss of $55.3 million in its second quarter.

LIVN : 82.93 (-1.01%)
LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer

LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2021.

LIVN : 82.93 (-1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London,...

See More

Key Turning Points

3rd Resistance Point 86.25
2nd Resistance Point 85.11
1st Resistance Point 84.02
Last Price 82.93
1st Support Level 81.79
2nd Support Level 80.64
3rd Support Level 79.55

See More

52-Week High 90.25
Last Price 82.93
Fibonacci 61.8% 71.46
Fibonacci 50% 65.66
Fibonacci 38.2% 59.86
52-Week Low 41.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar